IDEX Corporation, based in Illinois, creates technologies that improve daily life, from electronics to clean water. Valued at $13.4 billion, the company has grown globally since 1988, with over 50 businesses in 20 countries. While the stock rose 8.8%, it’s now 21.1% below its peak. Despite a 20% decline in the past year, IDEX is trading above moving averages. Strong Q3 earnings, with $2.03 EPS and $879 million revenue, beat estimates. Health & Science Technologies grew 22%, boosting investor confidence. Wall Street rates IEX a “Moderate Buy” with a $192.27 target price, suggesting a 7.8% increase.

Read more at Barchart: Is IDEX Corp Stock Underperforming the Dow?